NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Paradigm BioCapital

Paradigm BioCapital

New York City, New Yorkparadigmbiocapital.com

Overview

Paradigm BioCapital is a hedge fund manager and investment adviser that primarily invests in transformative therapeutics and the biotechnology sector.

Year Founded

2020

Portfolio Companies

3

Investments

CompanyDateStageLead
Obsidian TherapeuticsApr 2026Private PlacementCo-investor
ElektrofiOct 2024Series CCo-investor
Acrivon TherapeuticsApr 2024PIPECo-investor
Obsidian TherapeuticsApr 2024Series CCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.